REBECCA NEDDEN: Open Payments
NPI 1194588178 · EUGENE, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$552 in 24 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $552
Food & beverage: $552
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 3 | $96 |
| Axsome Therapeutics, Inc. | 3 | $82 |
| Lundbeck LLC | 3 | $77 |
| Janssen Pharmaceuticals, Inc | 3 | $55 |
| Corium, LLC | 2 | $52 |
| Braeburn Inc. | 3 | $48 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| Collegium Pharmaceutical, Inc. | 2 | $37 |
| Teva Pharmaceuticals USA, Inc. | 1 | $25 |
| Alkermes, Inc. | 1 | $24 |
Products named: FANAPT, Auvelity, ABILIFY MAINTENA, SPRAVATO, Azstarys, BRIXADI, REXULTI, Jornay PM.
Industry payments across OR — which companies pay providers there.
